loadpatents
Patent applications and USPTO patent grants for SAIAH; Eddine.The latest application filed is for "rapamycin analogs and uses thereof".
Patent | Date |
---|---|
Rapamycin Analogs And Uses Thereof App 20220267352 - O'NEILL; David John ;   et al. | 2022-08-25 |
Caffeine inhibitors of MTHFD2 and uses thereof Grant 11,370,792 - Mainolfi , et al. June 28, 2 | 2022-06-28 |
Heteroaryl Rheb inhibitors and uses thereof Grant 11,339,144 - Mahoney , et al. May 24, 2 | 2022-05-24 |
Modulators of Sestrin-GATOR2 interaction and uses thereof Grant 11,325,924 - Fetalvero , et al. May 10, 2 | 2022-05-10 |
Aminopyrimidinyl compounds Grant 11,197,867 - Fensome , et al. December 14, 2 | 2021-12-14 |
Aminopyrimidinyl Compounds App 20210377495 - FENSOME; Andrew ;   et al. | 2021-12-02 |
Heteroaryl Rheb Inhibitors And Uses Thereof App 20210238165 - MAHONEY; Sarah ;   et al. | 2021-08-05 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20210228523 - SAIAH; Eddine ;   et al. | 2021-07-29 |
Rapamycin Analogs And Uses Thereof App 20210220339 - SAIAH; Eddine ;   et al. | 2021-07-22 |
Rapamycin Analogs And Uses Thereof App 20210186935 - O'NEILL; David John ;   et al. | 2021-06-24 |
Rapamycin analogs and uses thereof Grant 10,980,784 - Saiah , et al. April 20, 2 | 2021-04-20 |
Aminopyrimidinyl compounds Grant 10,980,815 - Fensome , et al. April 20, 2 | 2021-04-20 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20210047347 - FETALVERO; Kristina Michelle ;   et al. | 2021-02-18 |
Modulators of Sestrin-GATOR2 interaction and uses thereof Grant 10,912,750 - Saiah , et al. February 9, 2 | 2021-02-09 |
Bruton's Tyrosine Kinase Inhibitors App 20210002251 - Springer; John Robert ;   et al. | 2021-01-07 |
Bicyclic-Fused Heteroaryl or Aryl Compounds App 20200377511 - Trzupek; John David ;   et al. | 2020-12-03 |
Phenyl amino piperidine mTORC inhibitors and uses thereof Grant 10,844,013 - O'Neill , et al. November 24, 2 | 2020-11-24 |
Bruton's tyrosine kinase inhibitors Grant 10,815,213 - Springer , et al. October 27, 2 | 2020-10-27 |
Aminopyrimidinyl Compounds App 20200330477 - FENSOME; Andrew ;   et al. | 2020-10-22 |
Bicyclic-fused heteroaryl or aryl compounds Grant 10,793,579 - Trzupek , et al. October 6, 2 | 2020-10-06 |
Modulators of Sestrin-GATOR2 interaction and uses thereof Grant 10,752,644 - Fetalvero , et al. A | 2020-08-25 |
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF App 20200207716 - O'Neill; David John ;   et al. | 2020-07-02 |
Rapamycin analogs and uses thereof Grant 10,683,308 - Saiah , et al. | 2020-06-16 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20200079800 - Fetalvero; Kristina Michelle ;   et al. | 2020-03-12 |
Aminopyrimidinyl Compounds App 20200038409 - FENSOME; Andrew ;   et al. | 2020-02-06 |
PYRROLE mTORC INHIBITORS AND USES THEREOF App 20190389843 - O'Neill; David John ;   et al. | 2019-12-26 |
Rapamycin Analogs And Uses Thereof App 20190388401 - Saiah; Eddine ;   et al. | 2019-12-26 |
Aminopyrimidinyl compounds Grant 10,463,675 - Fensome , et al. No | 2019-11-05 |
Modulators of sestrin-GATOR2 interaction and uses thereof Grant 10,414,782 - Fetalvero , et al. Sept | 2019-09-17 |
Phenyl amino piperidine mTORC inhibitors and uses thereof Grant 10,414,727 - O'Neill , et al. Sept | 2019-09-17 |
Bicyclic-Fused Heteroaryl or Aryl Compounds App 20190270751 - Trzupek; John David ;   et al. | 2019-09-05 |
Bruton's Tyrosine Kinase Inhibitors App 20190202798 - Springer; John Robert ;   et al. | 2019-07-04 |
Bicyclic-fused heteroaryl or aryl compounds Grant 10,329,302 - Trzupek , et al. | 2019-06-25 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Grant 10,316,018 - Lee , et al. | 2019-06-11 |
Bruton's tyrosine kinase inhibitors Grant 10,266,513 - Springer , et al. | 2019-04-23 |
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators App 20190092750 - LEE; KATHERINE LIN ;   et al. | 2019-03-28 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20190048029 - Fetalvero; Kristina Michelle ;   et al. | 2019-02-14 |
Rapamycin Analogs And Uses Thereof App 20190031683 - Saiah; Eddine ;   et al. | 2019-01-31 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Grant 10,174,000 - Lee , et al. J | 2019-01-08 |
Caffeine Inhibitors Of Mthfd2 And Uses Thereof App 20180370972 - Mainolfi; Nello ;   et al. | 2018-12-27 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20180333381 - Saiah; Eddine ;   et al. | 2018-11-22 |
Modulators of sestrin-GATOR2 interaction and uses thereof Grant 10,100,066 - Fetalvero , et al. October 16, 2 | 2018-10-16 |
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators App 20180244646 - LEE; KATHERINE LIN ;   et al. | 2018-08-30 |
Bicyclic-Fused Heteroaryl Or Aryl Compounds App 20180230127 - ANDERSON; DAVID RANDOLPH ;   et al. | 2018-08-16 |
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF App 20180127370 - O'Neill; David John ;   et al. | 2018-05-10 |
Bicyclic-Fused Heteroaryl or Aryl Compounds App 20180127432 - Trzupek; John David ;   et al. | 2018-05-10 |
Sepiapterin reductase inhibitors Grant 9,963,462 - Tebbe , et al. May 8, 2 | 2018-05-08 |
Bicyclic-fused heteroaryl or aryl compounds Grant 9,879,022 - Trzupek , et al. January 30, 2 | 2018-01-30 |
Bruton's Tyrosine Kinase Inhibitors App 20170283393 - Springer; John Robert ;   et al. | 2017-10-05 |
Aminopyrimidinyl Compounds App 20170239264 - FENSOME; Andrew ;   et al. | 2017-08-24 |
Aminopyrimidinyl compounds Grant 9,663,526 - Fensome , et al. May 30, 2 | 2017-05-30 |
Modulators Of Sestrin-gator2 Interaction And Uses Thereof App 20170114080 - Fetalvero; Kristina Michelle ;   et al. | 2017-04-27 |
Sepiapterin Reductase Inhibitors App 20170096435 - Tebbe; Mark Joseph ;   et al. | 2017-04-06 |
Bicyclic-Fused Heteroaryl or Aryl Compounds App 20160347760 - Trzupek; John David ;   et al. | 2016-12-01 |
Bicyclic-fused heteroaryl or aryl compounds Grant 9,458,168 - Trzupek , et al. October 4, 2 | 2016-10-04 |
Bruton's Tyrosine Kinase Inhibitors App 20150291554 - Springer; John Robert ;   et al. | 2015-10-15 |
Bicyclic-Fused Heteroaryl or Aryl Compounds App 20150284405 - Trzupek; John David ;   et al. | 2015-10-08 |
Indole Based Receptor Crth2 Antagonists App 20110105509 - Kaila; Neelu ;   et al. | 2011-05-05 |
Cytokine inhibitors Grant 7,919,617 - Boman , et al. April 5, 2 | 2011-04-05 |
Cytokine inhibitors Grant 7,897,599 - Boman , et al. March 1, 2 | 2011-03-01 |
Alpha-ketoamides And Derivatives Thereof App 20100273797 - Boman; Erik ;   et al. | 2010-10-28 |
Alpha-ketoamides and derivatives thereof Grant 7,749,999 - Boman , et al. July 6, 2 | 2010-07-06 |
Cytokine Inhibitors App 20100093734 - Boman; Erik ;   et al. | 2010-04-15 |
Cytokine Inhibitors App 20100093735 - Boman; Erik ;   et al. | 2010-04-15 |
11-Beta HSD1 Inhibitors App 20100029648 - Xiang; Jason Shaoyun ;   et al. | 2010-02-04 |
11-beta HSD1 inhibitors Grant 7,632,838 - Xiang , et al. December 15, 2 | 2009-12-15 |
Methods for Identifying Risk of Type II Diabetes and Treatments Thereof App 20080199480 - Langdown; Maria L. ;   et al. | 2008-08-21 |
Method for Preparing Halogenated Amines App 20080188659 - Saiah; Eddine ;   et al. | 2008-08-07 |
PTP1B inhibitors App 20080004325 - Lee; Jinbo ;   et al. | 2008-01-03 |
11-Beta HSD 1 inhibitors App 20070219198 - Xiang; Jason Shaoyun ;   et al. | 2007-09-20 |
Modulators of calcitonin and amylin activity App 20070088163 - Pryor; Kent ;   et al. | 2007-04-19 |
Cytokine inhibitors App 20050107399 - Boman, Erik ;   et al. | 2005-05-19 |
Compounds for the treatment of HIV infection App 20040248850 - Ernst, Justin T. ;   et al. | 2004-12-09 |
Tetrahydroquinoline derivatives as antithrombotic agents Grant 6,825,208 - Zhou , et al. November 30, 2 | 2004-11-30 |
Tetrahydroquinoline derivatives as antithrombotic agents App 20030225110 - Zhou, Jinglan ;   et al. | 2003-12-04 |
NCAGE Code | 4S4Y7 | SAIAH EDDINE |
CAGE Code | 4S4Y7 | SAIAH, EDDINE |
DUNS | 800302817 | SAIAH, EDDINE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.